Darwin Global Management

Latest statistics and disclosures from Darwin Global Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are INSM, BLTE, ABVX, RVMD, ROIV, and represent 99.96% of Darwin Global Management's stock portfolio.
  • Added to shares of these 5 stocks: RVMD (+$205M), ROIV (+$180M), ABVX (+$30M), BLTE, DNTH.
  • Started 3 new stock positions in RVMD, DNTH, ROIV.
  • Reduced shares in these 4 stocks: INSM (-$633M), CDTX (-$220M), WVE (-$125M), CAPR (-$23M).
  • Sold out of its positions in CAPR, CDTX, WVE.
  • Darwin Global Management was a net seller of stock by $-582M.
  • Darwin Global Management has $3.8B in assets under management (AUM), dropping by -23.66%.
  • Central Index Key (CIK): 0001839209

Tip: Access up to 7 years of quarterly data

Positions held by Darwin Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Darwin Global Management

Darwin Global Management holds 6 positions in its portfolio as reported in the March 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Insmed Com Par $.01 (INSM) 68.3 $2.6B -19% 17M 153.32
 View chart
Belite Bio Sponsored Ads (BLTE) 12.1 $456M 3.1M 149.18
 View chart
Abivax Sa Sponsored Ads (ABVX) 9.3 $352M +9% 3.5M 101.50
 View chart
Revolution Medicines (RVMD) 5.4 $205M NEW 2.2M 92.71
 View chart
Roivant Sciences SHS (ROIV) 4.8 $180M NEW 6.8M 26.41
 View chart
Dianthus Therapeutics (DNTH) 0.0 $1.5M NEW 17k 83.92
 View chart

Past Filings by Darwin Global Management

SEC 13F filings are viewable for Darwin Global Management going back to 2020

View all past filings